Applied Filters
Conformis launches implant lawsuit against J&J subsidiary
US medtech company Conformis has filed a lawsuit against J&J Medical Devices-owned DePuy Synthes, alleging that it infringed on its custom implant and surgery software patents.
Fed Circ. agrees Bio-Rad infringed 10x patents
The US Court of Appeals for the Federal Circuit has affirmed a US International Trade Commission (ITC) decision that ruled Bio-Rad Laboratories had infringed three 10x Genomics patents.
Moldex-Metric hits Honeywell with false advertising suit
Honeywell has been targeted in a recent complaint from competitor Moldex-Metric over a newly-launched “antimicrobial” earplug dispenser, which Moldex claims is falsely advertised.
PTAB invalidates Sanofi injector patent
Mylan Pharmaceuticals has succeeded in getting the Patent Trial and Appeal board (PTAB) to invalidate an injector patent held by French pharmaceutical company Sanofi
Arthrex prevails in patent dispute over wrist fracture device
In a win for medical device maker Arthrex, a federal judge in Delaware has ruled that its wrist-plating system does not infringe a patent owned by competitor TriMed Technologies.
Abbott unit prevails in dispute over catheter patent
In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing.
Snyders revives patent claims against St Jude Medical
Snyders Heart Valve has been successful in reviving patent claims in an on-going dispute against St Jude Medical.
Medical tech leads 2020 innovation at the EPO
Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.
Federal Circuit affirms PTAB’s Baxter ruling
The US Court of Appeals for the Federal Circuit has affirmed decisions from the Patent Trial and Appeal Board, knocking out two Baxter patents.
Senator calls on Biden to reject COVID IP waiver
Thom Tillis, ranking member of the senate IP subcommittee, has urged US president Joe Biden to oppose ‘harmful’ proposals to waive rights related to COVID-19 vaccines currently in discussions at the World Trade Organisation.
